NKX6-2 and amyotrophic lateral sclerosis: Altered expression of transcription factors NKX6-2 and RUNX3, relative to controls, further emphasizes transcription as a central pathological mechanism in ALS-TD patients (Fig. S11; Supplementary Data 10).